EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Fernando Moraes
Sheila Hazin
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moraes, F.
Right arrow Articles by Moraes, C. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moraes, F.
Right arrow Articles by Moraes, C. R.

Eur J Cardiothorac Surg 1999;15:309-313
© 1999 Elsevier Science NL


Surgery for endomyocardial fibrosis revisited1

Fernando Moraes, Cleuza Lapa, Sheila Hazin, Euclides Tenorio, Claudio Gomes, Carlos R. Moraes

Division of Thoracic Surgery, Department of Surgery, Federal University of Pernambuco, Heart Institute of Pernambuco, Recife, Brazil

Received 21 September 1998; received in revised form 11 January 1999; accepted 12 January 1999.

Corresponding author. Tel.: +55-81-2315-968; fax: +55-81-2210-382.

Objective: To identify life expectancy after surgery for endomyocardial fibrosis (EMF) and the events that influence it. Methods: Eighty-three patients with EMF underwent endocardial decortication and atrioventricular valve replacement or repair, between December 1977 and December 1997. There were 66 (79.6%) female and 17 (20.4%) male patients, ranging in age from 4 to 59 years (mean, 31). Thirty-seven (44.5%) had biventricular disease, 34 (41.0%) had disease of the right ventricle alone and 12 (14.5%) had EMF confined to the left ventricle. All were in functional class III or IV (New York Heart Association classification). Results: Sixty-eight (81.9%) patients survived the operation and were followed up for periods ranging from 2 months to 17 years. The total follow-up time was 6290 patient/months (mean, 92 months). There were 15 late deaths, but in six, the cause was not related to the underlying disease. Four (5.8%) patients presented recurrence of the fibrosis and were reoperated on and in six (8.8%), EMF appeared in the other ventricle. Five (7.3%) patients were reoperated on to replace either a valve prosthesis or a native valve which had been preserved during the first procedure. Only 24 (45%) of the 53 surviving patients are in functional class I or II. The actuarial probability of survival at 17 years, including operative mortality, was 55%. Conclusion: Surgical treatment of EMF should be considered a palliative procedure because surgery does not alter the progressive nature of the disease. However, surgical therapy is recommended for patients with EMF and heart failure as it is their only hope of survival.

Key Words: Endomyocardial fibrosis • Cardiomyopathy • Surgery




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
K. R. Vaidyanathan, R. Venkatraman, M. N. Sankar, and K. M. Cherian
Endomyocardial Fibrosis in an Adult Mimicking Left Ventricular Mass
Ann. Thorac. Surg., September 1, 2008; 86(3): 1004 - 1006.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
A. O. Mocumbi, M. B. Ferreira, D. Sidi, and M. H. Yacoub
A Population Study of Endomyocardial Fibrosis in a Rural Area of Mozambique
N. Engl. J. Med., July 3, 2008; 359(1): 43 - 49.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
A. O. Mocumbi, S. Yacoub, and M. H Yacoub
Neglected tropical cardiomyopathies: II. Endomyocardial fibrosis
Heart, March 1, 2008; 94(3): 384 - 390.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
A. O. Mocumbi, D. Sidi, P. Vouhe, and M. Yacoub
An innovative technique for the relief of right ventricular trabecular cavity obliteration in endomyocardial fibrosis.
J. Thorac. Cardiovasc. Surg., October 1, 2007; 134(4): 1070 - 1072.
[Full Text] [PDF]


Home page
HeartHome page
B. M Mayosi
Contemporary trends in the epidemiology and management of cardiomyopathy and pericarditis in sub-Saharan Africa
Heart, October 1, 2007; 93(10): 1176 - 1183.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. M. Cherian, B. R. Jagannath, S. Nayar, and K. M. Cherian
Successful reoperation after 17 years in a case of endomyocardial fibrosis.
Ann. Thorac. Surg., September 1, 2006; 82(3): 1115 - 1117.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
A. Tang, J. Karski, J. Butany, and T. David
Severe mitral regurgitation in acute eosinophilic endomyocarditis: repair or replacement?
Interactive CardioVascular and Thoracic Surgery, June 1, 2004; 3(2): 406 - 408.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
K. Yie, S. Sung, D. Kim, and J. Woo
Bidirectional cavopulmonary shunt as a rescue procedure for right ventricular endomyocardial fibrosis
Interactive CardioVascular and Thoracic Surgery, March 1, 2004; 3(1): 86 - 88.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1999 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.